Penn Announces Unique Bioethics Internship
Takes Ethics into "The Real World;" Mutual Benefit Expected
(Philadelphia, PA) -- The Center for Bioethics at the University
of Pennsylvania School of Medicine is inaugurating a unique internship
with a world-leading science company.
The foundational four-week internship, which begins on August 1, will
take place at Pioneer Hi-Bred International, Inc., a DuPont compamy, which
is headquartered in Des Moines, Iowa. Pioneer is the world's leading developer
and supplier of advanced plant genetics to farmers worldwide.
The graduate-level internship is designed to be mutually beneficial to
the company and those in the bioethics field. Pioneer anticipates that
the internship will help heighten bioethical awareness and capacity within
the organization. The Center for Bioethics expects an increase in understanding
of the potential ethical dilemmas endemic to the agriculture industry,
with particular attention to biotechnology-related challenges.
The recipient of the first internship is James Howard, a Masters student
in bioethics and research ethics at the University of Pennsylvania. Howard
will work across the company to develop a framework for helping employees
take ethics fully into account in the development and application of new
plant technologies in emergent countries. As part of this process, he
will conduct a comprehensive literature review and interview a cross section
of Pioneers employees.
"This initiative is a natural progression of the company's core values
and the work that we perform at the Center for Bioethics," said Arthur
Caplan, PhD, Director of the Center for Bioethics and Chair of
the Department of Medical Ethics at Penn. "It will increase awareness
and consideration of potential social implications of new techniques in
food production and processing, especially as they relate to aiding the
hungry in developing countries."
The internship is the product of collaboration between the DuPont Biotechnology
External Advisory Panel and the Center for Bioethics. The Panel is an
independent entity that helps the organization guide actions and decisions
related to biotechnology. Dr. Caplan was a member for four year and helped
develop its Bioethic Guiding Principles.
The Center for Bioethics at Penn's School of Medicine is a leader in bioethics
research and its deployment in the ethical, efficient, and compassionate
practice of the life sciences and medicine. The Center has become a world-renowned
educational and research enterprise that employs over 20 full and part-time
faculty with appointments in a number of schools and departments at Penn
including medicine, law, nursing, business, education, philosophy, psychology,
sociology, religious studies, public policy, and public health. It is
currently celebrating its 10th anniversary.
PENN Medicine is a $2.7 billion enterprise dedicated
to the related missions of medical education, biomedical research, and
high-quality patient care. PENN Medicine consists of the University of
Pennsylvania School of Medicine (founded in 1765 as the nation's first
medical school) and the University of Pennsylvania Health System.
Penn’s School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #4 in the nation in U.S. News &
World Report’s most recent ranking of top research-oriented medical
schools. Supporting 1,400 fulltime faculty and 700 students, the School
of Medicine is recognized worldwide for its superior education and training
of the next generation of physician-scientists and leaders of academic
The University of Pennsylvania Health System includes: its flagship hospital,
the Hospital of the University of Pennsylvania, consistently rated one
of the nation’s “Honor Roll” hospitals by U.S. News
& World Report; Pennsylvania Hospital, the nation's first hospital;
Penn Presbyterian Medical Center; a faculty practice plan; a primary-care
provider network; two multispecialty satellite facilities; and home health
care and hospice.